Adalimumab

Small for gestational age (length)

R analysis
id Study   Lib. in paper Exposition period    Study type  Control type 
 
Tags OR 95%CI x1/n1 x0/n0 no cases no exposed ROB Ref.
S5069
R13222
Chambers (Controls unexposed, disease free), 2019 Lenght < 10th centile for Gestational Age At Birth at least 1st trimester prospective cohort unexposed, disease free excluded Adjustment: No 1.51 [0.64;3.55]
excluded (control group)
13/205   8/190 21 205
ref
S5068
R13207
Chambers (Controls, sick), 2019 Lenght < 10th centile for Gestational Age At Birth at least 1st trimester prospective cohort unexposed, sick Adjustment: No 1.05 [0.41;2.67] 13/205   6/99 19 205
ref
Total 1 studies 1.05 [0.41;2.68] 19 205
x1: number of endpoints among exposed, n1: number of exposed; x0: number of endpoints among non exposed, n0: number of non exposed; C: calculated odds ratio from numbers of events and effectives

Forest plot

StudyTE95% CIn casesn exposedweightROBABCDEF Chambers (Controls, sick), 2019Chambers, 2019 1 1.05[0.41; 2.67]192050%ROB confusion: NAROB selection: NAROB classification: NAROB missing: NAROB mesure: NAROB reporting: NA0.55.01.0ROB: A: confusion, B: selection, C: classification, D: missing, E: measurement, F: reportinglow,moderate,serious,critical,unclear,

1: Controls, sick;

Sensitivity analysis

SubsetTE95% CIn casesn exposedkI2 Type of studies cohort studiescohort studies 1.05[0.41; 2.68]19205 -NAChambers (Controls, sick), 2019 1 case control studiescase control studies 0 Type of controls unexposed, sickunexposed, sick 1.05[0.41; 2.68]19205 -NAChambers (Controls, sick), 2019 1 Tags Adjustment   - No  - No 1.05[0.41; 2.68]19205 -NAChambers (Controls, sick), 2019 1 All studiesAll studies 1.05[0.41; 2.68]19205 -NAChambers (Controls, sick), 2019 10.55.01.0

Publication bias and p-hacking diagnosis

funnel plot

Funnel plot not drawn. Less than 3 points.

Asymetry test p-value = NaN (by Egger's regression)

not enought points

p values plot

Funnel plot not drawn. Less than 3 points.

Sub-groups analysis using all included studies

excluded 5069

Sub-groupsTE95% CIn casesn exposedkI2ROB type of controls unexposed controls (disease free or unspecified)unexposed controls (disease free or unspecified) 1.51[0.64; 3.56]21205 -NAChambers (Controls unexposed, disease free), 2019 1 unexposed, sick controlsunexposed, sick controls 1.05[0.41; 2.68]19205 -NAChambers (Controls, sick), 2019 10.510.01.0